PRCT

20.89

5.77% 1.14

Handel nachbörslich: 20.89

Procept Biorobotics Corp (PRCT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$19.75

Offen:

$20.13

24-Stunden-Volumen:

1.23M

Relative Volume:

0.80

Marktkapitalisierung:

$1.19B

Einnahmen:

$322.02M

Nettoeinkommen (Verlust:

$-102.47M

KGV:

-11.42

EPS:

-1.8295

Netto-Cashflow:

$-80.57M

1W Leistung:

-0.67%

1M Leistung:

-28.19%

6M Leistung:

-36.37%

1J Leistung:

-64.72%

1-Tages-Spanne:

$19.63

$21.00

1-Wochen-Bereich:

$19.55

$21.88

52-Wochen-Spanne:

$19.35

$62.17

Procept Biorobotics Corp Stock (PRCT) Company Profile

Firmenname

Procept Biorobotics Corp

Sektor

Healthcare (1096)

Branche

Medical Devices (140)

Telefon

(650) 232-9832

Adresse

150 BAYTECH DRIVE, SAN JOSE

Mitarbeiter

888

Twitter

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

PRCT's Discussions on Twitter

Compare PRCT vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PRCT Procept Biorobotics Corp	20.89	1.19B	322.02M	-102.47M	-80.57M	-1.8295
ABT Abbott Laboratories	93.93	163.61B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	329.78	126.42B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.87	107.36B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.77	66.54B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	92.21	53.09B	6.30B	1.07B	1.09B	1.8406

Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-06	Eingeleitet	Robert W. Baird	Neutral
2026-02-26	Herabstufung	BofA Securities	Neutral → Underperform
2026-02-26	Herabstufung	Oppenheimer	Outperform → Perform
2025-12-12	Eingeleitet	UBS	Buy
2025-12-08	Herabstufung	BofA Securities	Buy → Neutral
2025-09-02	Hochstufung	Oppenheimer	Perform → Outperform
2025-07-09	Eingeleitet	Stephens	Overweight
2025-07-07	Eingeleitet	Oppenheimer	Perform
2024-12-02	Eingeleitet	Morgan Stanley	Overweight
2024-11-14	Eingeleitet	Jefferies	Hold
2023-08-11	Eingeleitet	Piper Sandler	Overweight
2023-05-31	Eingeleitet	William Blair	Outperform
2022-10-31	Eingeleitet	BTIG Research	Neutral
2022-10-25	Eingeleitet	Truist	Buy
2022-09-02	Eingeleitet	Wells Fargo	Overweight
2022-07-15	Eingeleitet	KeyBanc Capital Markets	Overweight
2022-06-23	Eingeleitet	B. Riley Securities	Buy
2021-10-11	Eingeleitet	BofA Securities	Buy
2021-10-11	Eingeleitet	Cowen	Outperform
2021-10-11	Eingeleitet	Goldman	Neutral
2021-10-11	Eingeleitet	Guggenheim	Buy
2021-10-11	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten

Jul 10, 2026

Pooja Sharma Net Worth (2026) - GuruFocus

Jul 10, 2026

Jul 09, 2026

Procept BioRobotics shares slide after Leerink downgrade cites rising competitive risks - MSN

Jul 09, 2026

Jul 07, 2026

Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT) - The Globe and Mail

Jul 07, 2026

PROCEPT BioRobotics stock stays guided by procedure demand - AD HOC NEWS

Jul 07, 2026

Jul 06, 2026

Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30 - marketscreener.com

Jul 06, 2026

Jul 05, 2026

PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 - Stocktwits

Jul 05, 2026

Jul 03, 2026

PRCTProcept BioRobotics Corp Dividends - Finviz

Jul 03, 2026

Jul 02, 2026

Truist cuts Procept BioRobotics stock rating on reimbursement concerns By Investing.com - Investing.com South Africa

Jul 02, 2026

Truist cuts Procept BioRobotics stock rating on reimbursement concerns - Investing.com

Jul 02, 2026

PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap? - simplywall.st

Jul 02, 2026

Jun 30, 2026

PROCEPT BioRobotics (PRCT) Is Up 7.2% After WATER IV Milestones Spotlight Aquablation’s Oncology Potential – Has The Bull Case Changed? - simplywall.st

Jun 30, 2026

Jun 29, 2026

Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential - Insider Monkey

Jun 29, 2026

Price to book forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView

Jun 29, 2026

Jun 28, 2026

Price to sales forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView

Jun 28, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView

Jun 27, 2026

Price to sales forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView

Jun 27, 2026

Enterprise value to EBIT forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView

Jun 27, 2026

Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right Now - Insider Monkey

Jun 25, 2026

Jun 24, 2026

Evercore ISI initiates Procept BioRobotics stock with outperform rating - Investing.com UK

Jun 24, 2026

Evercore ISI initiates Procept BioRobotics stock with outperform rating By Investing.com - Investing.com Australia

Jun 24, 2026

5 Best Robotics and Automation Stocks to Invest In - Insider Monkey

Jun 24, 2026

Jun 23, 2026

PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed? - simplywall.st

Jun 23, 2026

Jun 20, 2026

PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds - simplywall.st

Jun 20, 2026

Jun 19, 2026

Transcript : PROCEPT BioRobotics Corporation Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 12 - marketscreener.com

Jun 19, 2026

Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now? - Insider Monkey

Jun 19, 2026

Jun 18, 2026

Top 3 Health Care Stocks You'll Regret Missing In Q2 - Benzinga

Jun 18, 2026

Jun 17, 2026